Benjamin Jackson Sells Shares of SERA
Benjamin Jackson, General Counsel at SERA, sold 2,179 shares on June 11, 2026.
Key Points
- Benjamin Jackson, General Counsel at SERA, sold 2,179 shares for $4,379.79 on June 11, 2026.
- Shares of SERA traded at $1.91, with insider sales reported by several executives.
- Craig-Hallum initiated coverage of SERA with a buy rating and a $6.00 price target on June 4, 2026.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Benjamin Jackson, General Counsel at SERA, sold 2,179 shares of the company on June 11, 2026. The shares were sold at an average price of $2.01, totaling $4,379.79. This transaction was not part of a pre-planned trading program.
Other Institutional Activity in SERA
BAKER BROS. ADVISORS LP maintained its position in SERA with 5,498,170 shares valued at approximately $11.16 million. WHETSTONE CAPITAL ADVISORS, LLC trimmed its holdings by 152,824 shares, bringing its total to 3,306,889 shares worth about $6.71 million. ABERDEEN GROUP PLC increased its stake by 271,076 shares, ending with 2,550,775 shares valued at around $5.18 million. Meanwhile, PSP RESEARCH LLC and VANGUARD CAPITAL MANAGEMENT LLC both initiated new positions, each holding 2,396,685 and 1,204,115 shares, respectively.
Sera Prognostics, Inc. Stock Down 8.0%
Shares of SERA traded at approximately $1.91. The stock's recent trading activity involves a range of institutional movements, reflecting varying levels of confidence and strategy among investors.
Insider Buying and Selling at Sera Prognostics, Inc.
On June 11, 2026, several SERA executives reported selling shares. Chief Medical Officer Tiffany Inglis sold 362 shares, CEO Zhenya Lindgardt sold 6,990 shares, CFO Austin Aerts sold two separate lots of 2,037 and 5,440 shares, and Chief Commercial Officer Dyaarl Lee Jr. sold 4,739 shares, all at $2.01 per share. These transactions were not part of planned trading programs.
Analysts Set New Price Targets
On June 4, 2026, Craig-Hallum initiated coverage of SERA with a buy rating and set a price target of $6.00. Earlier, on March 23, 2023, Citigroup maintained its hold rating with a price target of $4.25. The consensus among analysts is mixed, with a range of ratings reflecting varied outlooks on SERA's potential.
About SERA
SERA operates in the [industry sector] and is involved in [describe core business activities]. The company is headquartered in [location] and led by CEO Zhenya Lindgardt. SERA's business strategy focuses on [key focus areas].
Bottom Line
Insider activity at SERA, including the sale by Benjamin Jackson, provides insights into the company's internal sentiment. The recent analyst coverage by Craig-Hallum adds a positive outlook with a buy rating. Investors often watch these insider transactions and analyst ratings to gauge the company's potential future performance.
Get Sera Prognostics, Inc. alerts
New 13F filings, insider trades, and analyst moves on $SERA, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.